Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
Authors
Keywords
B cells, Drug screening, T cells, Protein structure databases, Kinase inhibitors, Protein kinases, RNA interference, Drug interactions
Journal
PLoS One
Volume 15, Issue 5, Pages e0233089
Publisher
Public Library of Science (PLoS)
Online
2020-05-28
DOI
10.1371/journal.pone.0233089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- To Bind or Not to Bind: Unravelling GPCR Polypharmacology
- (2018) Patrick M. Sexton et al. CELL
- 5-HT 2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology
- (2018) Yao Peng et al. CELL
- The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
- (2018) Alexandra B. Keenan et al. Cell Systems
- Open Targets Platform: new developments and updates two years on
- (2018) Denise Carvalho-Silva et al. NUCLEIC ACIDS RESEARCH
- The Bruton’s tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages
- (2017) Lingyan Ping et al. Oncotarget
- In silico methods to address polypharmacology: current status, applications and future perspectives
- (2016) Antonio Lavecchia et al. DRUG DISCOVERY TODAY
- New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells
- (2016) Jörg C. Heinrich et al. Oncotarget
- CrossDocker: a tool for performing cross-docking using Autodock Vina
- (2016) Jamal Shamsara SpringerPlus
- BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
- (2015) Michael K. Gilson et al. NUCLEIC ACIDS RESEARCH
- PLIP: fully automated protein–ligand interaction profiler
- (2015) Sebastian Salentin et al. NUCLEIC ACIDS RESEARCH
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- sc-PDB: a 3D-database of ligandable binding sites—10 years on
- (2014) Jérémy Desaphy et al. NUCLEIC ACIDS RESEARCH
- SwissTargetPrediction: a web server for target prediction of bioactive small molecules
- (2014) David Gfeller et al. NUCLEIC ACIDS RESEARCH
- HitPick: a web server for hit identification and target prediction of chemical screenings
- (2013) X. Liu et al. BIOINFORMATICS
- Encoding Protein–Ligand Interaction Patterns in Fingerprints and Graphs
- (2013) Jérémy Desaphy et al. Journal of Chemical Information and Modeling
- Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key
- (2013) V. Joachim Haupt et al. PLoS One
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Angiogenesis drives psoriasis pathogenesis
- (2010) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Structural space of protein-protein interfaces is degenerate, close to complete, and highly connected
- (2010) M. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Data completeness—the Achilles heel of drug-target networks
- (2008) Jordi Mestres et al. NATURE BIOTECHNOLOGY
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- SuperPred: drug classification and target prediction
- (2008) M. Dunkel et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More